Venturangi Capital

Adan Medical Innovation, S.L. is a biotechnology company based in Barcelona, Spain, specializing in the development of medical devices that enhance the management of anaphylaxis. Founded in 2014, the company focuses on improving the quality of life for patients experiencing severe allergic reactions that require epinephrine. Its flagship product, AnAPPhylaxis, is a smart case for epinephrine auto-injectors that connects to a mobile application, providing users with real-time information about the condition of the medication. The device also features alerts for users who forget their auto-injectors and activates an emergency action plan during an anaphylactic event, offering step-by-step instructions for drug administration and notifying predefined contacts with the user's location. Additionally, Adan Medical Innovation is developing WE SAVE, a smart box designed for public spaces to increase accessibility to epinephrine auto-injectors in emergencies.

Adan Medical Innovation, S.L. is a biotechnology company based in Barcelona, Spain, specializing in the development of medical devices that enhance the management of anaphylaxis. Founded in 2014, the company focuses on improving the quality of life for patients experiencing severe allergic reactions that require epinephrine. Its flagship product, AnAPPhylaxis, is a smart case for epinephrine auto-injectors that connects to a mobile application, providing users with real-time information about the condition of the medication. The device also features alerts for users who forget their auto-injectors and activates an emergency action plan during an anaphylactic event, offering step-by-step instructions for drug administration and notifying predefined contacts with the user's location. Additionally, Adan Medical Innovation is developing WE SAVE, a smart box designed for public spaces to increase accessibility to epinephrine auto-injectors in emergencies.